Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Regeneron
Sort By
Newest First
1 / 1
1 / 1
Expansion
Governor Cuomo Announces Regeneron's $1.8 Billion Expansion in Westchester County
Regeneron
PR-M07-21-013-843
Jul 23, 2021
COVID
Regeneron Phase III Trial Shows 81% Reduced Risk of COVID
Regeneron
PR-M04-21-014
Apr 16, 2021
Collaboration
BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo Combination in Melanoma
BioNTech
PR-M08-20-NI-06
Jul 31, 2020
Partnership
Regeneron Expands Partnership with RNAi Drug Developer Alnylam
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-013
Apr 10, 2019
Patent
Regeneron and Sanofi Strongly Disagree with Verdict Upholding Three of Five Amgen U.S. Patent Claims Relating to PCSK9 Antibodies
Sanofi
PR-M02-19-NI-059
Feb 26, 2019
Immuno-oncology
Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
Sanofi
PR-M01-19-NI-031
Jan 10, 2019
Immuno-oncology
Sanofi and Regeneron Immuno-oncology Collaboration Ending
Nice Insight
PAO-M01-19-NI-012
Jan 09, 2019
FDA Approval
FDA Approves Asthma Indication for Dupixent® (dupilumab)
Regeneron
PR-M10-18-NI-090
Oct 25, 2018
Study Results
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Teva Pharmaceutical Industries
PR-M09-18-NI-059
Sep 20, 2018
Regulatory
Regeneron Provides Regulatory Update on EYLEA® (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration
Regeneron
PR-M09-18-NI-016
Sep 07, 2018
Collaboration
Regeneron and bluebird bio Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer
Regeneron
PR-M08-18-NI-054
Aug 14, 2018
